Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Biochemistry|April 10, 2010
Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptorHugo R Arias, Ruo-Xu Gu, Dominik Feuerbach, et al.The International Journal of Biochemistry & Cell Biology|May 30, 2015
Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sitesHugo R Arias, Katarzyna M Targowska-Duda, Dominik Feuerbach, et al.Neurochemistry International|June 28, 2015
The antidepressant-like activity of nicotine, but not of 3-furan-2-yl-N-p-tolyl-acrylamide, is regulated by the nicotinic receptor β4 subunitHugo R Arias, Katarzyna M Targowska-Duda, Dominik Feuerbach, et al.Neurochemistry International|May 25, 2010
Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.Journal of Biomolecular Structure & Dynamics|January 25, 2018
Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico studyKatarzyna M Targowska-Duda, Agnieszka A Kaczor, Krzysztof Jozwiak, et al.Behavioural Brain Research|July 8, 2017
Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the ratMarie-Louise G Wadenberg, Dina Manetti, Maria Novella Romanelli, et al.International Review of Neurobiology|June 6, 2003
Unique general anesthetic binding sites within distinct conformational states of the nicotinic acetylcholine receptorHugo R Arias, William R Kem, James R Trudell, et al.Journal of Natural Products|July 6, 2019
Alkaloids Purified from Aristotelia chilensis Inhibit the Human α3β4 Nicotinic Acetylcholine Receptor with Higher Potencies Compared with the Human α4β2 and α7 SubtypesHugo R Arias, Marcelo O Ortells, Dominik Feuerbach, et al.Biochemistry|February 16, 2006
Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptorsHugo R Arias, Pankaj Bhumireddy, Guillermo Spitzmaul, et al.European Journal of Pharmacology|May 7, 2026
Ibogalogs and their Pyridoindole Homologs Activate or Inhibit the 5-HT2B Receptor by Modulating the Distance Between Transmembrane Segments TM3 and TM6 in the Orthosteric SiteHugo R Arias, Deborah Rudin, Xintong Ren, et al.Pageof 10